Determinants of medication adherence and blood pressure control among hypertensive patients in Hong Kong: A cross-sectional study

International Journal of Cardiology

Volumn 182, Issue C, 2015, Pages 250-257

  Kang, Candy D ^a   Tsang, Prilla P M ^a   Li, Winson T L ^a   Wang, Harry H X ^a   Liu, Kirin Q L ^a,b   Griffiths, Sian M ^a   Wong, Martin C S ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Blood pressure control; Cross sectional study; Determinant; Hong Kong; Hypertension; Medication adherence

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; BLOOD PRESSURE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DRUG EFFECTS; FEMALE; HONG KONG; HUMAN; HYPERTENSION; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; MORBIDITY; MULTICENTER STUDY; ODDS RATIO; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; TRENDS;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; HONG KONG; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MORBIDITY; ODDS RATIO; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84947201830     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.12.064     Document Type: Article

References (31)

1. World Health Organization, A global brief on hypertension: silent killer, global public health crisis, 2003. (Switzerland).
2. The 14th Annual Scientific Meeting of the Institute of Cardiovascular Science and Medicine (ICSM), Hong Kong, 18 December 2010, Journal of the Hong Kong College of Cardiology, v. 18 n. 2, 2010, p. 62 (abstract no. no. IL1).
3. M.C.S.Wong, H.H.X.Wang, M.C.M. Leung, C.S.H. Tsang, S.V. Lo, S.M. Griffiths, The rising prevalence of self-reported hypertension among Chinese subjects: a population-based study from 121 895 household interviews, QJM-An Int J Med (2014). http://dx.doi.org/10.1093/qjmed/hcu129.
4. J. Woo, et al., An estimate of chronic disease burden and some economic consequences among the elderly Hong Kong population, J. Epidemiol. Community Health 51 (5) (1997) 486-489.
5. M.C.S. Wong, H.H.X. Wang, C.S.K. Cheung, E.L.H. Tong, A.C.H. Sek, N.T. Cheung, et al., Factors associated with multimorbidity and its link with poor blood pressure control among 223,286 hypertensive patients, Int. J. Cardiol. 177 (2014) 202-208.
6. H.H.X. Wang, J.J.Wang, S.Y.S. Wong, M.C.S. Wong, F.J. Li, P.X. Wang, et al., Epidemiology of multimorbidity in China and implications for the healthcare system: cross-sectional survey among 162,464 community household residents in southern China, BMC Med. 12 (2014) 188. http://dx.doi.org/10.1186/s12916-014-0188-0.
7. K.I. Gallacher, G. Batty, G. McLean, S.W. Mercer, B. Guthrie, C.R. May, et al., Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden, BMC Med. 12 (2014) 151.
8. H.H.X. Wang, M.C.S. Wong, S.Y.S. Wong, J.L. Tang, B.P. Yan, C.M. Yu, et al., The impact of cardiovascular multimorbidity on healthcare service utilisation under three primary care organisational models in China, Int. J. Cardiol. 163 (2013) S1-S2. http://dx.doi.org/10.1016/S0167-5273(13)70530-8.
9. World Health Organization, Adherence to long-term therapies: policy for action, Meeting Report, 2001 (June 4-5 2001).
10. World Health Organization, Adherence to Long-term Therapies: Evidence for Action, 2003. (Switzerland).
11. M.C.S. Wong, J.Y. Jiang, J.L. Tang, A. Lam, H. Fung, S.W. Mercer, Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data, BMC Health Serv. Res. 8 (2008) 138.
12. M.C.S. Wong, W.W.S. Tam, C.S.K. Cheung, H.H.X. Wang, E.L.H. Tong, A.C.H. Sek, et al., Drug adherence and the incidence of coronary heart disease- and stroke-specific mortality among 218,047 patients newly prescribed an antihypertensive medication: a five-year cohort study, Int. J. Cardiol. 168 (2013) 928-933.
13. M.C.S. Wong, W.W.S. Tam, C.S.K. Cheung, E.L.H. Tong, A.C.H. Sek, N.T. Cheung, et al., Medication adherence to first-line antihypertensive drug class in a large Chinese population, Int. J. Cardiol. 167 (2013) 1438-1442.
14. G.K.Y. Lee, H.H.X. Wang, K.Q.L. Liu, Y. Cheung, D.E. Morisky, et al., Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky medication adherence scale, PLoS ONE 8 (4) (2013) e62775.http://dx.doi.org/10.1371/journal.pone.0062775.
15. M. Burnier, Medication adherence and persistence as the cornerstone of effective antihypertensive therapy, Am. J. Hypertens. 19 (2006) 1190-1196.
16. M. Krousel-Wood, S. Thomas, P. Muntner, D. Morisky, Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients, Curr. Opin. Cardiol. 19 (2004) 357-362.
17. M.C.S. Wong, J. Liu, S.L. Zhou, S.W. Li, X.F. Su, H.H.X. Wang, et al., The association between multimorbidity and poor adherence with cardiovascular medications, Int. J. Cardiol. 177 (2014) 477-482.
18. E.M. Donald, A. Alfonso, K.W. Marie, J.W. Harry, Predictive validity of a medication adherence measure in an outpatient setting, J. Clin. Hypertens. 10 (5) (2008) 348-354.
19. J. Wang, R.W. Bian, Y.Z. Mo, Validation of the Chinese version of the eight-item Morisky medication adherence scale in patients with type 2 diabetes mellitus, J. Clin. Gerontol. Geriatr. 4 (2013) 119-122.
20. M.C.S. Wong, C.H.M. Wu, H.H.X. Wang, H.W. Li, E.M.T. Hui, A.T. Lam, et al., Association between the 8-item Morisky Medication Adherence Scale (MMAS-8) score and glycaemic control among Chinese diabetes patients, J. Clin. Pharmacol. (2014).http://dx.doi.org/10.1002/jcph.408.
21. M.C.S. Wong, K.Q.L. Liu, H.H.X. Wang, C.L.S. Lee, M.W.M. Kwan, K.W. Lee, et al., Effectiveness of a pharmacist-led drug counseling on enhancing antihypertensive adherence and blood pressure control: a randomized controlled trial, J. Clin. Pharmacol. 53 (2013) 753-761.
22. K.Q.L. Liu, M.C.S. Wong, H.H.X. Wang, C.L.S. Lee, M.W.M. Kwan, Y. Cheung, et al., Effectiveness of a community-based medication counseling service on enhancing medication adherence among patients prescribed antihypertensive agents: a randomized controlled trial, Int. J. Cardiol. 163 (Suppl. 2) (2013) S7. http://dx.doi.org/10.1016/S0167-5273(13)70544-8.
23. S.L. Chen, J.C. Tsai, W.L. Lee, Psychometric validation of the Chinese version of the Illness Perception Questionnaire-Revised for patients with hypertension, J. Adv. Nurs. 64 (5) (2008) 524-534.
24. M.S. Paulsen, M. Andersen, J.L. Thomsen, H. Schroll, P.V. Larsen, J. Lykkegaard, et al., Multimorbidity and blood pressure control in 37 651 Hypertensive patients from Danish general practice, J. Am. Heart Assoc. 2 (2012) e004531.
25. A.D. Oliveira-Filho, J.A. Barreto-Filho, S.J.F. Neves, D.P. Lyra, et al., Association between the 8-item Morisky Medication Adherence Scale (MMAS-8) and blood pressure control, Arq. Bras. Cardiol. 99 (1) (2012) 649-658.
26. M.A. Krousel-Wood, P. Muntner, L. Kawasaki, K.B. DeSalvo, Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting, J. Clin. Hypertens. 9 (2007) 179-186.
27. K.Q.L. Liu, M.C.S. Wong, H.H.X. Wang, K.S.D. Liu, B.P.Y. Yan, C.M. Yu, et al., Self-perceived health status is associated with optimal compliance to antihypertensive medications, Eur. Heart J. Suppl. 14 (Suppl. A) (2012) A28. http://dx.doi.org/10.1093/eurheartj/sur028.
28. K.Q.L. Liu, M.C.S.Wong, H.H.X.Wang, Knowledge and attitudes associated with selfcare practices among Chinese type 2 diabetics: a systematic review, J. Diabetes Invest. 3 (Suppl. 1) (2012) 246. http://dx.doi.org/10.1111/jdi.12013.
29. E. Degli Esposti, A. Sturani, M. Di Martino, P. Falasca, M.V. Novi, et al., Long-term persistence with antihypertensive drugs in new patients, J. Hum. Hypertens. 16 (2002) 439-444.
30. B.L. Carter, Adherence, Quality of Life, Cost Effectiveness, and the Role of the Pharmacist, in: G.Y.H. Lip, J.E. Hall (Eds.), Comprehensive Hypertension, Mosby Elsevier, Philadelphia, 2007, pp. 1119-1127.
31. H.H.X. Wang, S.Y.S. Wong, M.C.S. Wong, X.L.Wei, J.J. Wang, D.K.T. Li, et al., Patients' experiences in different models of community health centers in southern China, Ann. Fam. Med. 11 (2013) 517-526.